Clinical Trial Imaging Market is expected to reach US$ 2,480.32 million by 2028

Publisher: The Insight Partners

Tomography Segment to Dominate Clinical Trial Imaging Market During 2022–2028

According to our new research study on "Clinical Trial Imaging Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality, Offering, and End User," the clinical trial imaging market size is expected to grow from US$ 1,610.70 million in 2022 to US$ 2,480.32 million by 2028; it is estimated to register a CAGR of 7.6% from 2023 to 2028.

Key factors driving the market growth are accelerated clinical trial activities in the pharmaceutical and biotechnology industries, and a spur in the number of CROs offering medical imaging services. However, high investment and standardized infrastructure requirements hinder the growth of the clinical trial imaging market.

North America is leading the global clinical trial imaging market. The US is the largest and fastest-growing market for clinical trial imaging in this region. The country is emerging as a leading clinical research destination. In addition to this, innovative products launched by companies for various processes in clinical trials boost the growth of the clinical trial imaging market in the US. Nearly half of the total clinical trials conducted globally are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and global acceptance of generated data. A World Health Organisation (WHO) report states that the US registered the highest number of clinical trials (157,618) in 2021.

Clinical Trial Imaging Market, by Region, 2022 (%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPHE100001201 Source: The Insight Partners Analysis

The following table illustrates the number of clinical trials registered in the US with the number of total patients recruited in them, along with the share of the US for the said parameters.

Source: ClinicalTrial.gov report

Innovative products launched by companies for applications in clinical trials further boost the growth of the clinical trial imaging market in the US. Medical Metrics, a CRO providing imaging services for clinical trials, offers "Assessa." This product assists in the improvement of decision-making in drug discovery and related clinical studies, particularly in the discovery of drugs for neurological disorders, such as dementia; cognitive impairment; and Alzheimer's, Schizophrenia, Parkinson's Disease, and other memory-related diseases.

The clinical trial imaging market, by modality, is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-Ray, echocardiography, and others. The tomography segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2023–2028. In tomography, shadows of superimposed structures are blurred by a moving X-ray tube that is used for X-ray imaging. Computed tomography (CT) scan imaging used in research and clinical trials combines X-ray images taken from different angles, followed by computer processing to provide cross-sectional images of bones, blood vessels, and soft tissues. Linear and nonlinear tomography systems operate in a similar way—a tube moves in one direction, while a film cassette moves in the opposite direction, centered around a fulcrum in both techniques.

eResearch Technology Inc, Calyx Inc, ICON PLC, VIDA Diagnostics Inc, WCG Clinical Inc, BioTelemetry Inc, Medical Metrics Inc, Medpace Holdings Inc, Radiant Sage LLC, and IXICO plc. are among the key companies operating in the clinical trial imaging market.

The report segments the clinical trial imaging market as follows:

Based on modality, the clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. By offering, the clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The clinical trial imaging market, by end user, is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. Based on geography, the clinical trial imaging market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com